In the JMML patients, the clonogenic assays from PB showed hypersensitivity to GM-CSF and spontaneous CFU-GM growth (except in one patient previously treated with chemotherapy at another center who did not show spontaneous CFU-GM growth) (Table I). Here, CSF2 is linked to juvenile myelomonocytic leukemia.